Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeAdvanced

Health Management and White 500 Certification

First written in FY2024. 2 of 3 entries say "Advanced", first in FY2025. Latest entry: FY2026.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024AdvancedFY2025 – FY20262024: 120242025: 120252026: 12026
Same theme, other companies
Maintaining Health and Productivity Management Outstanding Organization (White 500) certificationA theme 136 companies write about · 0 as a headwind · 138 as a tailwind

82 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 136 companies compared. The sentences above are computed from all 136.
Moved together

"Overseas Business Expansion Focused on Asia" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Overseas Business Expansion Focused on Asia2×
  3. 2FY2025 Sales and Profitability Targets and the Vision of a Total Healthcare Company2×
  4. 3CO2 Emissions Reduction and Energy-Saving Targets2×
  5. 4Continued Investment in R&D and Production Facilities2×
  6. 5Revenue and Profit Growth in the Animal Health Business2×
  7. 6Group Structure Comprising Subsidiaries and Affiliates2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.